Analystreport

Cytokinetics, Inc. (NASDAQ: CYTK) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating.

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview